SCHEMBL5164550

SCHEMBL5164550

COCCCNC(=O)Cc1ccc(N)cc1N

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
TSHR P16473 1/20 0.46
LMNA P02545 3/20 0.46
KDM4E B2RXH2 3/20 0.46
POLB P06746 2/20 0.46
HPGD P15428 3/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.43
HTT P42858 1/20 0.43
HSD17B10 Q99714 1/20 0.43
IDO1 P14902 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GLA P06280 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5160950 0.92 KDM4E (0.50) TSHRKDM4EPOLBHPGDKMT2A
SCHEMBL5163460 0.85 HPGD (0.50) ALDH1A1TSHRLMNAKDM4EHPGD
SCHEMBL5162503 0.83 PTGS2 (0.36) HPGDHTTL3MBTL1GAA
SCHEMBL5162590 0.81 L3MBTL1 (0.42) ALDH1A1TSHRLMNAKDM4EHPGD
Ammonia Solution, Strong SCHEMBL5307556 0.80 L3MBTL1 (0.41) ALDH1A1TSHRLMNAKDM4EHPGD
SCHEMBL5159800 0.80 ALDH1A1 (0.47) ALDH1A1TSHRLMNAKDM4EPOLB
SCHEMBL5165340 0.80 CA12 (0.37) TSHRKDM4EHPGDMEN1KMT2A
SCHEMBL5164364 0.80 GAA (0.36) ALDH1A1LMNAKDM4EPOLBHPGD
Ammonia Solution, Strong SCHEMBL5332401 0.79 GAA (0.35) ALDH1A1LMNAKDM4EPOLBHPGD
SCHEMBL5162095 0.78 EPHX2 (0.39) ALDH1A1TSHRKDM4EPOLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070067923-A1 1,3-Diaminobenzene derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US claimed
WO-2007026312-A1 1,3-DIAMINOBENZENE DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO claimed
EP-1760072-A1 1,3-diaminobenzene derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-07 EP claimed
US-20070067923-A1 1,3-Diaminobenzene derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US disclosed
WO-2007026312-A1 1,3-DIAMINOBENZENE DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO disclosed
EP-1760072-A1 1,3-diaminobenzene derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070067923-A1 1,3-Diaminobenzene derivatives and colorants comprising these compounds KRT18, DSP, DSG1 ALDH1A1 12/4885TSHR 4478/4885LMNA 2461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.